AGE-RELATED-CHANGES IN BETA-ADRENERGIC NEUROEFFECTOR SYSTEMS IN THE HUMAN HEART

Background Aging decreases cardiac beta-adrenergic responsiveness in m odel systems and in humans in vivo. The purpose of this study was to c omprehensively evaluate the age-related changes in the beta-receptor-G protein-adenylyl cyclase complex in nonfailing human hearts. Methods and Results Twenty-six nonfailing explanted human hearts aged 1 to 71 years were obtained from organ donors and subjected to pharmacological investigation of beta-adrenergic neuroeffector systems. When the popu lation was subdivided into the 13 youngest and 13 oldest subjects, tot al beta-receptor density assessed by maximum [I-125]ICYP binding (beta (max)) was reduced in older hearts by 37% in left ventricles and 31% i n right ventricles (both P<.05), and the downregulation was confined t o the beta(1) subtype (r=-.78 left ventricle beta(1), density versus d onor age). Older donor hearts exhibited a 3- to 4-fold rightward shift of ICYP-isoproterenol (ISO) competition curves and demonstrated 43% f ewer receptors in a high-affinity agonist binding state (P<.05). Older hearts exhibited decreased adenylyl cyclase stimulation by ISO, by zi nterol (beta(2)-agonist), and by the G protein-sensitive probes forsko lin, Gpp(NH)p, and NaF. In contrast, there was no change in response t o manganese, a specific activator of the adenylyl cyclase catalytic su bunit. Toxin-catalyzed ADP ribosylation in membranes prepared from old er versus younger hearts revealed a 29% to 30% reduction (P<.05) with cholera toxin (G(s)) but no difference with pertussis toxin (G(i)). Th e systolic contractile response of isolated right ventricular trabecul ae to ISO was decreased by 46%, with a 10-fold increase in ISO EC(50) in older relative to younger donor hearts. Conclusions There is a prof ound decrease in cardiac beta-adrenergic responsiveness with aging. Th is occurs by multiple mechanisms including downregulation and decrease d agonist binding of beta(1)-receptors, uncoupling of beta(2)-receptor s, and abnormal G protein-mediated signal transduction.